CD8A and COVID-19: In addition, the percentage of TREM-2+CD8+ T cells was also up-regulated in patients with nonsevere (18.83 ± 2.15%) or severe (48.9 ± 6.31%) COVID-19, compared with healthy donors (7.2 ± 0.84%) (fig.